Systematic review suggests novel bionic cryoprotectants improve cryopreservation efficiency with low toxicity compared to traditional agents.

This systematic review synthesizes evidence regarding the use of novel bionic cryoprotectants for the preservation of animal genetic resources. The scope encompasses various biological materials, including sperm, oocytes, and embryos, comparing these bioinspired agents against traditional cryoprotectants. The authors aimed to assess cryopreservation efficiency and toxicity profiles across the included studies.

Key findings indicate that novel bioinspired cryoprotectants exhibit low toxicity and higher cryopreservation efficiency compared to traditional cryoprotectants. The review highlights improved tolerability associated with these new agents. However, the authors note that specific effect sizes, absolute numbers, and p-values were not reported in the available data. Consequently, the magnitude of benefit remains undefined.

Several limitations affect the interpretation of this evidence. The sample size and setting were not reported, and the review did not provide specific adverse event rates beyond general tolerability descriptions. Without quantitative data, the strength of the association between bioinspired agents and improved outcomes cannot be precisely quantified. The authors acknowledge these gaps in the reporting of primary outcomes.

Practice relevance suggests new insights into expanding the use of bioinspired cryoprotectants in the preservation of animal genetic resources. Clinicians and researchers should consider these findings when evaluating cryopreservation methods for animal models. Further research with reported numerical data is necessary to confirm efficacy and safety profiles definitively. The current evidence supports potential utility but requires validation through more detailed reporting.